Bone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousTransplantation, AutologousGraft vs Host DiseaseStem Cell TransplantationTransplantation ConditioningBone MarrowBone Marrow CellsStem CellsTissue DonorsWhole-Body IrradiationGraft SurvivalHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraBusulfanHistocompatibility TestingHematopoietic Stem CellsKidney TransplantationTreatment OutcomeRecurrenceRemission InductionAnemia, AplasticCombined Modality TherapyHistocompatibilityGraft vs Tumor EffectImmunosuppressive AgentsLeukemia, Myeloid, AcuteBone and BonesGraft RejectionRetrospective StudiesTime FactorsTransplantation, IsogeneicCyclophosphamideSurvival AnalysisHeart TransplantationCord Blood Stem Cell TransplantationTransplantation ImmunologyBone Marrow PurgingMesenchymal Stem Cell TransplantationCell TransplantationSurvival RateDisease-Free SurvivalHematopoiesisLung TransplantationHepatic Veno-Occlusive DiseaseLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunosuppressionMice, Inbred C57BLGraft vs Leukemia EffectGranulocyte Colony-Stimulating FactorPrecursor Cell Lymphoblastic Leukemia-LymphomaMultiple MyelomaMelphalanHLA AntigensMyeloablative AgonistsCell DifferentiationLymphocyte DepletionLymphoma, Non-HodgkinMyelodysplastic SyndromesT-LymphocytesAcute DiseaseBone Marrow DiseasesHematologic DiseasesAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem Cell MobilizationRadiation ChimeraCyclosporineAdult Stem CellsCytomegalovirus InfectionsFollow-Up StudiesLeukemia, MyeloidTransplantationAntigens, CD34Lymphocyte TransfusionOrgan TransplantationSevere Combined ImmunodeficiencyChimerismLeukocyte TransfusionGraft vs Host ReactionEmbryonic Stem CellsCells, CulturedAntilymphocyte SerumCytarabineIslets of Langerhans TransplantationFlow CytometrySalvage TherapyChimeraMesenchymal Stromal CellsColony-Forming Units AssayCarmustineLiving DonorsVidarabinePrognosisBone Marrow ExaminationEtoposideHodgkin Disease